HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 co-Infected Men. - No Study Results Posted - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 co-Infected Men.

This study has been completed.

Study NCT00378976 Information provided by University of Washington

First Received: September 19, 2006 Last Updated: December 11, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	July 2004
Estimated Primary Completion Date:	No date given

No publications provided by University of Washington

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Zuckerman RA, Lucchetti A, Whittington WL, Sánchez J, Coombs RW, Magaret A, Wald A, Corey L, Celum C. HSV suppression reduces seminal HIV-1 levels in HIV-1/HSV-2 co-infected men who have sex with men. AIDS. 2009 Feb 20;23(4):479-83.

Zuckerman RA, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, Zuñiga R, Magaret AS, Wald A, Corey L, Celum C. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. J Infect Dis. 2007 Nov 15;196(10):1500-8. Epub 2007 Oct 31.

Back to top of Main Content